AVL

2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one

Find entries where: AVL

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	2-methyl-1-[2-(propan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]propan-1-one
Identifiers	2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one
Formula	C₁₄ H₁₈ N₂ O
Molecular Weight	230.306
Type	NON-POLYMER
Isomeric SMILES	CC(C)c1c(c2ccccn2n1)C(=O)C(C)C
InChI	InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3
InChIKey	ZJVFLBOZORBYFE-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	0
Bond Count	36
Aromatic Bond Count	10

Drug Info: DrugBank

DrugBank ID	DB05266
Name	Ibudilast
Groups	investigational
Description	Ibudilast is an anti-inflammatory and neuroprotective oral agent which shows an excellent safety profile at 60 mg/day and provides significantly prolonged time-to-first relapse and attenuated brain volume shrinkage in patients with relapsing-remitting (RR) and/or secondary progressive (SP) multiple sclerosis (MS). Ibudilast is currently in development in the U.S. (codes: AV-411 or MN-166), but is approved for use as an antiinflammatory in Japan.
Synonyms	Ibudilastum Ibudilast
Indication	For the treatment of multiple sclerosis, asthma, and cerebrovascular disease.
Categories	Anti-Asthmatic Agents Antiplatelet agents Autonomic Agents Bronchodilator Agents Cardiovascular Agents Drugs for Obstructive Airway Diseases Enzyme Inhibitors Hematologic Agents Heterocyclic Compounds, Fused-Ring Leukotriene Antagonists Peripheral Nervous System Agents Phosphodiesterase 5 Inhibitors Phosphodiesterase Inhibitors Respiratory System Agents Vasodilating Agents
ATC-Code	R03DC04
CAS number	50847-11-5

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSD...	unknown	inhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNL...	unknown	inhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	MENLGVGEGAEACSRLSRSRGRHSMTRAPKHLWRQPRRPIRIQQRFYSDP...	unknown	inhibitor
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRL...	unknown	inhibitor
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	MAVPGDAARVRDKPVHSGVSQAPTAGRDCHHRADPASPRDSGCRGCWGDL...	unknown	inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682